<DOC>
	<DOCNO>NCT02224339</DOCNO>
	<brief_summary>Hypothesis : Identification vulnerable atherosclerotic plaque ( without neovascularization ) use carotid CEUS independent predictor MACE ( clinical risk factor , stress echo wall motion result , carotid ultrasound two-dimensional speckle track strain index ) . Primary Aims : 1 . Evaluate diagnostic role carotid CEUS two-dimensional speckle track strain image detection carotid plaque : - To determine feasibility safety Carotid CEUS Two-dimensional speckle track strain image SE . - To determine carotid CEUS two-dimensional speckle track strain imaging finding associate coronary angiographic result patient undergo clinically indicate cardiac catheterization . - To determine diagnostic accuracy CEUS identify vulnerable atherosclerotic plaque neovascularization compare carotid MRI , subset patient . 2 . Evaluate prognostic role carotid CEUS two-dimensional speckle track strain image prediction MACE : - To determine plaque identification ( without neovascularization ) Carotid CEUS SE improve overall prediction MACE stress echo result alone - To determine Carotid ultrasound two-dimensional speckle track strain index improve overall prediction MACE stress echo result alone . - To determine detection plaque neovascularization Carotid CEUS independent predictor MACE ( clinical risk factor , stress echo wall motion result , carotid ultrasound two-dimensional speckle track strain index ) .</brief_summary>
	<brief_title>New Technologies Determine Carotid Plaque Vulnerability</brief_title>
	<detailed_description>This prospective cohort study . - Participating Site ( ) ( principal investigator parenthesis ) enrol patient : Mayo Clinic Rochester site ( PI : Sharon Mulvagh , MD ) . Only subject provide informed consent include . Patients prospectively identified time present echocardiography laboratory schedule undergo exercise dobutamine stress test reason know suspected CAD . The patient undergo carotid artery ultrasound without contrast , carotid artery strain image stress echo contrast set detailed study flow chart . MRI perform subset randomly select patient ( 50 pt ) ascertain diagnostic accuracy CEUS plaque identification . All patient follow review electronic medical record ( EMR ) and/ phone contact use standardize approved questionnaire survey 6 12 24 month ultrasound study complete . The outcome major adverse cardiac event ( MACE ) include cardiac death , acute coronary syndrome ( ACS ) , unstable angina pectoris , nonfatal acute myocardial infarction , stroke . Study eligibility criterion : age ≥ 18 year , suspect know CAD refer stress echo lab . Study Exclusion criterion : Previous carotid surgery angioplasty ; Stroke , cardiogenic shock , pulmonary hypertension , heart failure ; serious disease ; Prior contraindication contrast agent . 1.Study Procedures : Carotid artery ultrasound ( 2D CEUS ) perform rest phase stress echocardiography patient . Transthoracic SE [ exercise dobutamine ] perform experienced sonographer/echocardiographer accord American Society Echocardiography recommendation . 2.Imaging protocol : Commercially available ultrasound system ( Vivid , GE Medical Systems , Milwaukee , WI , USA ) equip phased-array transducer , contrast image technology utilized . OptisonTM ( GE Healthcare Inc. , Princeton , NJ ) ] use CEUS leave ventricular opacification ( LVO ) wall motion score index ( WMSI ) . 2D carotid US , carotid strain , CEUS Contrast SE perform succession . The contrast agent administer per package insert guideline dosing . The commercially available real time coherent pulse image ( CPI ) low Mechanical index contrast image scheme utilized . 1 . Standard carotid ultrasound : Longitudinal short axis image carotid artery acquire digitally store line strain analysis . The short axis image acquire 1.5 cm bifurcation . 2 . Carotid CEUS : The contrast agent inject via peripheral vein bolus per package insert . The appearance contrast effect observe inside lumen carotid artery within 15-30 second injection . A real-time contrast-enhanced carotid cine-loop ( longitudinal short axis ) include image obtain least 3 second 5 minute appearance contrast effect lumen carotid artery , acquire digitally store line analysis . The entire imaging session digitize recorded videotape digitally subsequent offline analysis . All echocardiographic measure make blinded fashion single observer . 3 . MRI : 50 pt randomly select undergo Carotid MRI within episode care ( +/- 4 week ) determine diagnostic accuracy CEUS identify vulnerable atherosclerotic plaque neovascularization.The carotid image protocol involve standard 2D carotid ultrasound image CEUS imaging follow . 3.Trial Variables : Patient identifier study store single electronic spreadsheet password protect stored Mayo EED network . Unique identifier convert study identifier ( ID ) . Only primary study investigator access spreadsheet . The study ID number maintain statistical software spreadsheet store password protect departmental server Mayo EED . Data enter statistical software computer analysis , archive storage . All study data review study investigator ensure complete data collection . All study data use research purpose , impact medical care and/or decision-making . There publication variable potentially involved patient identification . Patient confidentiality strictly protect . Trial variable include : 1 . Demographics Labs : Age , gender , BMI Cardiovascular risk factor Symptom/disease duration ( year ) Medications Laboratory Investigations include Lipids ( µmol/L ) hs-CRP ( mg/L ) ( available clinically ) BS HbA1C ( diabetes mellitus ) 2 . Carotid imaging : Intima medial thickness ( IMT ) plaque identification ( 2-D baseline ) Longitudinal short axis image carotid artery obtain measure CIMT , define distance lead edge lumen-intima interface lead edge media-adventitia interface . The measurement region approximately 1.5 cm distal carotid bulb . Atherosclerotic plaque define lesion focal IMT ≥1.1 mm protrude vessel wall lumen . The plaque echogenicity assess Gray-Weale 's ( type I-V ) : type I : dominantly echolucent plaque , thin echogenic cap ; type II : predominantly echolucent lesion &lt; 50 % echogenic area ; type III : predominantly echogenic lesion &lt; 50 % echolucent area ; type IV : uniformly echogenic lesion ; type V : plaque heavy calcification acoustic shadow . Types I II fatty plaque , type III IV mixed plaque type V calcify plaque . 3 . Strain imaging Measurements perform offline workstation use Echo PAC software ( GE Healthcare Inc. , Princeton , NJ ) . The media-adventitia interface carotid arterial wall manually trace still frame image . The circumferential radial strain curve automatically obtain . Measurements peak radial circumferential strain , strain rate obtain . If carotid plaque identify : An ROI ( regional interest ) place plaque 3 different region : 2 shoulder region fibrous cap top , measurement result peak longitudinal , radial circumferential strain , strain rate acquire software . 4 . Carotid CEUS The enhancement plaque categorize visual interpretation , G0 : visible microbubbles within plaque ; G1 : moderate microbubbles confine shoulder and/or adventitial side plaque ; G2 : extensive microbubbles throughout plaque , clear visible appearance bubble move plaque core . The quantitative enhancement plaque analyze use time-intensity curve . Quantitative parameter obtain : BI ( baseline intensity ) , PI ( peak intensity ) EI ( enhance intensity : peak intensity/ baseline intensity ) . Stress Echo : 5 . Stress echo data analysis per Mayo Clinic Echocardiography Laboratory ( Rochester MN ) stress protocol generate clinical report . The analysis utilizes American Heart Association/American Society Echocardiography 17-segment model . Wall motion evaluate use previously establish criterion ( 29 ) rest stress wall motion score index ( WMSIs ) calculate . Wall motion assess score follow : 1=normal , 2=hypokinetic , 3=akinetic 4=dyskinetic . 6 . Magnetic Resonance Imaging ( MRI ) validation subset : 50 pt randomly select undergo Carotid MRI ( per standard image protocol ) within episode care ( +/- 4 week ) . The carotid MRI study send Michigan State University via secure VPN similarly secure transfer . The reader blind clinical data . The study utilize General Electric 3T scanner dedicate carotid coil . Multi-contrast carotid plaque sequence include 3D time-of-flight MR angiography ( TOF ) , 3D black-blood sequence optimize detect intraplaque hemorrhage ( MPRAGE ) pre-contrast black-blood T1 weighting ( T1W ) . During bolus administration single dose gadolinium base contrast agent , dynamic contrast enhance MR study ( DCE-MRI ) obtain well post-contrast black-blood T1 weight sequence ( CE-T1W ) . 7 . Outcomes : All patient follow review electronic medical record ( EMR ) and/ phone contact use standardize approved questionnaire survey 6 12 24 month ultrasound study complete . The outcome define presence absence major adverse cardiac event ( MACE ) include cardiac death , acute coronary syndrome ( ACS ) , unstable angina pectoris , nonfatal acute myocardial infarction , stroke . 4.Power sample size calculation : We use several publish paper reference sample size estimation . Odds ratio MACE rate Patient population Feinstein 2.5 ( 1.1-6.1 ) 25 % ( 37/147 ) 147 Kugiyama 2.52 ( 1.42-4.38 ) 28 % ( 84/304 ) 304 Patients recruit reference high risk know CAD . Since patient include spectrum CV risk , estimate hazard ratio 1.5-3.0 , MACE rate 5-20 % . Our statistical resource suggest sample 180 patient provide 80 % test power ( 2-tailed test α 0.05 ) detect association plaque neovascularization MACE ( HR 2.8 , MACE RATE 20 % ) . Anticipating ~20 % F/U failure withdrawal , inflate total 216 patient . The primary endpoint cumulative incidence cardiac death within 24 month followup . The secondary endpoint composite MACE . For followup data , miss data report missing , unavailable . 5.Statistical analysis Plan Baseline demographic descriptive analysis include age , gender , parity , weight , height , Body mass index ( BMI ) , body surface area ( BSA ) , cardiovascular risk factor , present . Counts percentage present categorical variable , mean ±standard deviation 95 % confidence interval describe continuous variable normality assumption meet . If distribution continuous parameter skew , transformation consider , median interquartile range ( IQR ) present . For analysis use two side P value le 0.05 significant test perform use SAS 9.1 ( SAS Institute , Cary , NC ) . Echo feasibility analysis evaluate report percentage analyzable plaque myocardial segment ( CEUS , WMSI strain ) . Safety use Optison contrast agent also evaluate report ( % ) adverse event ( categorize minor serious adverse event ) . Measures data report mean ± SD continuous variable ( include quantitative parameter contrast enhanced plaque quantitative parameter strain ) . The intraplaque neovascularization count displayed percentage . After SE CEUS examination , patient group result SE CEUS : group I : plaque neovascularization without abnormal wall motion ; group II : without plaque neovascularization abnormal wall motion ; group III : without plaque neovascularization abnormal wall motion ; group IV : plaque neovascularization abnormal wall motion . Continuous variable compare 2 group use unpaired t-tests . For comparison continuous variable ≥3 group , one-way analysis variance ( ANOVA ) follow Scheffé test perform . Frequencies compare use Chi square analysis . The correlation 2 continuous variable determine use linear regression analysis . The relationship cardiovascular risk factor grade plaque neovascularization examine use multiple logistic regression analysis . Cox proportion hazard model use estimate hazard ratio prediction CV . The Kaplan-Meier method use calculate coronary event-free survival patient without intraplaque contrast material enhancement . Intra- interobserver agreement assign grade plaque neovascularization evaluate use Cohen κ test . Observer reproducibility parameter assess use Bland-Altman 20 randomly assign patient , two independent observer blind clinical data . Intraobserver variability assess patient investigator 2 occasion least 1 month apart . All statistical analysis perform use JMP version 9 ( SPSS Inc , Chicago , IL ) .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Study eligibility criterion : age ≥ 18 year , suspect know CAD refer stress echo lab . Previous carotid surgery angioplasty ; Stroke , cardiogenic shock , pulmonary hypertension , heart failure ; serious disease ; Prior contraindication contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>carotid plaque</keyword>
	<keyword>Contrast-enhanced ultrasound</keyword>
	<keyword>Major Adverse Cardiovascular Events</keyword>
</DOC>